Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P Kevin Starr


  • Large Shareholder at Revolution Medicines Inc. (RVMD), 2020-09-11
  • Large Shareholder at Nurix Therapeutics Inc. (NRIX), 2020-07-30
  • Large Shareholder at Relay Therapeutics Inc. (RLAY), 2020-07-21
  • at Sage Therapeutics Inc. (SAGE), 2020-06-11
  • Large Shareholder at Pliant Therapeutics Inc. (PLRX), 2020-06-10
  • Large Shareholder at Fulcrum Therapeutics Inc. (FULC), 2019-07-22
  • Large Shareholder at Voyager Therapeutics Inc. (VYGR), 2018-09-19
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2018-09-04
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-08-24
  • Large Shareholder at Neon Therapeutics Inc. (NTGN), 2018-07-03
  • Large Shareholder, Director at Myokardia Inc (MYOK), 2018-03-07
  • Large Shareholder at Allena Pharmaceuticals Inc. (ALNA), 2017-11-06
  • Large Shareholder at Cytomx Therapeutics Inc. (CTMX), 2017-10-19
  • Large Shareholder at Global Blood Therapeutics Inc. (GBT), 2017-06-16
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2017-06-06
  • Large Shareholder at Blueprint Medicines Corp (BPMC), 2017-02-28
  • Large Shareholder at Jounce Therapeutics Inc. (JNCE), 2017-02-03
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-09-07
  • Director at Zafgen Inc. (ZFGN), 2015-09-25
  • Large Shareholder at Foundation Medicine Inc. (FMI), 2015-05-15
  • Large Shareholder, Director at Agios Pharmaceuticals Inc (AGIO), 2015-02-20
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2014-02-13
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SAGE $0.00 0 Director 0 2019-02-12 Filing
SAGE $168.28 24,000 Director 302,817 2018-04-18 Filing
SAGE $169.25 35,000 Director 326,817 2018-04-17 Filing
MYOK $42.00 816,326 Large Shareholder, Director 680,272 2018-01-03 Filing
MYOK $40.28 75,313 Large Shareholder, Director 70,763 2017-10-03 Filing